- Home
- PULM vs LASE Comparison
PULM vs LASE Comparison
Compare PULM & LASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- LASE
- Stock Information
- Founded
- PULM 2003
- LASE 2019
- Country
- PULM United States
- LASE United States
- Employees
- PULM N/A
- LASE N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- LASE Industrial Machinery/Components
- Sector
- PULM Health Care
- LASE Industrials
- Exchange
- PULM Nasdaq
- LASE Nasdaq
- Market Cap
- PULM 20.5M
- LASE 51.8M
- IPO Year
- PULM N/A
- LASE 2022
- Fundamental
- Price
- PULM $5.57
- LASE $2.95
- Analyst Decision
- PULM
- LASE
- Analyst Count
- PULM 0
- LASE 0
- Target Price
- PULM N/A
- LASE N/A
- AVG Volume (30 Days)
- PULM 10.9K
- LASE 472.4K
- Earning Date
- PULM 08-12-2025
- LASE 07-07-2025
- Dividend Yield
- PULM N/A
- LASE N/A
- EPS Growth
- PULM N/A
- LASE N/A
- EPS
- PULM N/A
- LASE N/A
- Revenue
- PULM $1,921,000.00
- LASE $4,962,487.00
- Revenue This Year
- PULM N/A
- LASE N/A
- Revenue Next Year
- PULM $134.88
- LASE N/A
- P/E Ratio
- PULM N/A
- LASE N/A
- Revenue Growth
- PULM N/A
- LASE 23.87
- 52 Week Low
- PULM $1.78
- LASE $1.58
- 52 Week High
- PULM $10.40
- LASE $19.80
- Technical
- Relative Strength Index (RSI)
- PULM 36.25
- LASE 51.51
- Support Level
- PULM $5.20
- LASE $2.74
- Resistance Level
- PULM $6.15
- LASE $3.08
- Average True Range (ATR)
- PULM 0.30
- LASE 0.34
- MACD
- PULM -0.05
- LASE -0.05
- Stochastic Oscillator
- PULM 22.70
- LASE 13.21
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About LASE Laser Photonics Corporation
Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.